Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
33
KVUE Quote, Financials, Valuation and Earnings
Last price:
$16.98
Seasonality move
:
1.43%
Day range:
$16.96 - $17.16
52-week range:
$14.02 - $25.17
Dividend yield:
4.85%
P/E ratio:
22.88x
P/S ratio:
2.18x
P/B ratio:
3.07x
Volume:
49.7M
Avg. volume:
39M
1-year change:
-21.24%
Market cap:
$32.6B
Revenue:
$15.5B
EPS (TTM):
$0.74
Analysts' Opinion
-
Consensus RatingKenvue, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $19.33, Kenvue, Inc. has an estimated upside of 13.59% from its current price of $17.02.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $17.00 representing 100% downside risk from its current price of $17.02.
Fair Value
-
According to the consensus of 13 analysts, Kenvue, Inc. has 13.59% upside to fair value with a price target of $19.33 per share.
KVUE vs. S&P 500
-
Over the past 5 trading days, Kenvue, Inc. has underperformed the S&P 500 by -1.89% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kenvue, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kenvue, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Kenvue, Inc. reported revenues of $3.8B.
Earnings Growth
-
Kenvue, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Kenvue, Inc. reported earnings per share of $0.21.
Enterprise value:
40.6B
EV / Invested capital:
2.06x
Price / LTM sales:
2.18x
EV / EBIT:
14.86x
EV / Revenue:
2.70x
PEG ratio (5yr expected):
0.67x
EV / Free cash flow:
24.85x
Price / Operating cash flow:
20.08x
Enterprise value / EBITDA:
12.30x
Gross Profit (TTM):
$8.7B
Return On Assets:
5.38%
Net Income Margin (TTM):
9.55%
Return On Equity:
13.85%
Return On Invested Capital:
7.47%
Operating Margin:
18.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $15.5B | $15.5B | $15B | $3.9B | $3.8B | |
| Gross Profit | $8.6B | $8.9B | $8.7B | $2.3B | $2.2B | |
| Operating Income | $3B | $2.8B | $2.7B | $700M | $713M | |
| EBITDA | $3.6B | $3.4B | $3.3B | $882M | $854M | |
| Diluted EPS | $0.92 | $0.55 | $0.74 | $0.20 | $0.21 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $5.5B | $5.9B | $5.9B | $6B | |
| Total Assets | -- | $26B | $27.1B | $26.9B | $27.2B | |
| Current Liabilities | -- | $3.9B | $5.2B | $5.9B | $6.2B | |
| Total Liabilities | -- | $7.1B | $16.2B | $16.3B | $16.6B | |
| Total Equity | -- | $18.9B | $10.9B | $10.6B | $10.6B | |
| Total Debt | -- | -- | $8.3B | $7.1B | $7.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.9B | $1.9B | $2.1B | $249M | $294M | |
| Cash From Investing | -$390M | -$558M | -$493M | -$56M | -$104M | |
| Cash From Financing | -$2.2B | -$1.4B | -$1.6B | -$162M | -$110M | |
| Free Cash Flow | $2.5B | $1.4B | $1.6B | $190M | $196M | |
KVUE
Sector
Market Cap
$32.6B
$125M
Price % of 52-Week High
67.62%
71.8%
Dividend Yield
4.85%
0%
Shareholder Yield
5.77%
2.32%
1-Year Price Total Return
-21.24%
-7.14%
Beta (5-Year)
--
0.257
Dividend yield:
4.85%
Annualized payout:
$0.81
Payout ratio:
100.24%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$17.23
200-day SMA
Sell
Level
$20.20
Bollinger Bands (100)
Sell
Level
15.52 - 20.02
Chaikin Money Flow
Sell
Level
-1.2B
20-day SMA
Sell
Level
$17.08
Relative Strength Index (RSI14)
Buy
Level
52.91
ADX Line
Buy
Level
21.83
Williams %R
Neutral
Level
-63.9477
50-day SMA
Buy
Level
$16.28
MACD (12, 26)
Buy
Level
0.20
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Sell
Level
-379.8M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.5073)
Buy
CA Score
(Annual)
Level (-0.2433)
Buy
Beneish M-Score
(Annual)
Level (-2.6224)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (0.1667)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.
Stock Forecast FAQ
In the current month, KVUE has received 2 Buy ratings 11 Hold ratings, and 0 Sell ratings. The KVUE average analyst price target in the past 3 months is $19.33.
-
Where Will Kenvue, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kenvue, Inc. share price will rise to $19.33 per share over the next 12 months.
-
What Do Analysts Say About Kenvue, Inc.?
Analysts are divided on their view about Kenvue, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kenvue, Inc. is a Sell and believe this share price will drop from its current level to $17.00.
-
What Is Kenvue, Inc.'s Price Target?
The price target for Kenvue, Inc. over the next 1-year time period is forecast to be $19.33 according to 13 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is KVUE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kenvue, Inc. is a Hold. 11 of 13 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of KVUE?
You can purchase shares of Kenvue, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kenvue, Inc. shares.
-
What Is The Kenvue, Inc. Share Price Today?
Kenvue, Inc. was last trading at $16.98 per share. This represents the most recent stock quote for Kenvue, Inc.. Yesterday, Kenvue, Inc. closed at $17.02 per share.
-
How To Buy Kenvue, Inc. Stock Online?
In order to purchase Kenvue, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get KVUE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KVUE
Sector
P/E ratio
22.88x
16.72x
PEG ratio
0.67x
0.13x
P/B ratio
3.07x
1.48x
Price / LTM sales
2.18x
0.51x
Growth Metrics
KVUE
Sector
Revenue growth
-3.51%
2.99%
Earnings growth
3.97%
5%
Revenue (5-year growth)
1.54%
3.32%
Earnings forecast
$0.26
$0.32
Profitability
KVUE
Sector
Profitability FY 2024
$9B
$263.1M
Return on invested capital
7.47%
4.48%
Return on assets
5.38%
3.08%
Return on equity
13.85%
7.59%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
2
Balance Sheet
KVUE
Sector
Total cash
$1.1B
$88.7M
Short term investments
--
$32.9M
Total assets
$25.6B
$1.1B
Long term debt
$7.9B
$6.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
